News

By João Luis D’Orey Facco Vianna

The Ministry of Industry and Commerce and the Brazilian Patent and Trademark Office launch a Public Consultation on a Proposal for dealing with the Patent Applications’ backlog

This Resolution will cover all applications filed in Brazil up to the date of its publication, excluding patent applications claiming pharmaceutical products or processes, divisional applications an certificates of addition.
 
After due requirements and formal conditions have been observed, the patent application still awaiting examination and not having been object of the presentation of subsidies will be allowed in 90 days. Opting out of this simplified allowance procedure will be possible.
 
Suggestions and comments can be presented until August 21st 2017, through this form, addressed to consulta.backlog@inpi.gov.br
 
We will keep you informed on any developments on this matter, as soon as they are available. Should you have any questions, our teams are available in Rio de Janeiro, São Paulo and Porto Alegre offices and, through the e-mail: mail@kasznarleonardos.com
 
 
Back

Last by João Luis D’Orey Facco Vianna

April 15, 2020

The Brazilian PTO establishes prioritization of technologies associated with the treatment and diagnosis of Covid-19

By means of publication made in the Official Gazette 2,570, dated April 7th, 2020, the Brazilian Patent Office promulgated Ordinance No. 149/2020, The Brazilian PTO establishes prioritization of technologies associated with the treatment and diagnosis of Covid-19

Ler notícia

October 25, 2019

BPTO publishes new rules to request participation on Patent Prosecution Highway (PPH) programs

The Brazilian Patent and Trademark Office (BPTO) published Resolution 225/19 which institutes rulings on the pilot project for the Patent Prosecution Highway BPTO publishes new rules to request participation on Patent Prosecution Highway (PPH) programs

Ler notícia

August 12, 2019

Pharmaceutical IP and competition law in Brazil: 2019

A Q&A guide to pharmaceutical IP and competition law in Brazil. The Q&A gives a high level overview of key issues including Pharmaceutical IP and competition law in Brazil: 2019

Ler notícia